Research Letters in Biochemistry
Volume 2009 (2009), Article ID 783035, 5 pages
doi:10.1155/2009/783035
Research Letter

What Differs on the Enzymatic Acetylation Mechanisms for Arylamines and Arylhydrazines Substrates? A Theoretical Study

Qing-An Qiao,1 Xiao-Min Sun,2 Jie Jing,1 Xin Chen,1 Hua-Yang Wang,3 Chuan-Lu Yang,3 and Zheng-Ting Cai4

1School of Chemistry and Materials Science, Ludong University, Yantai 264025, China
2Environment Research Institute, Shandong University, Jinan 250100, China
3School of Physics and Electronic Engineering, Ludong University, Yantai 264025, China
4Institute of Theoretical Chemistry, Shandong University, Jinan, Shandong 250100, China

Received 12 May 2009; Accepted 8 July 2009

Academic Editor: George Perry

Copyright © 2009 Qing-An Qiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. E. Hanna, “N-acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation,” Advances in Pharmacology, vol. 27, pp. 401–430, 1994.
  2. P. E. Hanna, “Metabolic activation and detoxification of arylamines,” Current Medicinal Chemistry, vol. 3, no. 3, pp. 195–210, 1996.
  3. D. W. Hein, D. M. Grant, and E. Sim, “Update on consensus arylamine N-acetyltransferase gene nomenclature,” Pharmacogenetics, vol. 10, no. 4, pp. 291–292, 2000.
  4. D. M. Grant, M. Blum, M. Beer, and U. A. Meyer, “Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes,” Molecular Pharmacology, vol. 39, no. 2, pp. 184–191, 1991.
  5. A. Upton, N. Johnson, J. Sandy, and E. Sim, “Arylamine N-acetyltransferases—of mice, men and microorganisms,” Trends in Pharmacological Sciences, vol. 22, no. 3, pp. 140–146, 2001. View at Publisher · View at Google Scholar
  6. J.-M. Dupret and D. M. Grant, “Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2,” Journal of Biological Chemistry, vol. 267, no. 11, pp. 7381–7385, 1992.
  7. M. Watanabe, T. Sofuni, and T. Nohmi, “Involvement of Cys69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium. Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms,” Journal of Biological Chemistry, vol. 267, no. 12, pp. 8429–8436, 1992.
  8. J. C. Sinclair, J. Sandy, R. Delgoda, E. Sim, and M. E. M. Noble, “Structure of arylamine N-acetyltransferase reveals a catalytic triad,” Nature Structural Biology, vol. 7, no. 7, pp. 560–564, 2000. View at Publisher · View at Google Scholar · View at PubMed
  9. J. Sandy, A. Mushtaq, A. Kawamura, J. Sinclair, E. Sim, and M. Noble, “The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis—an enzyme which inactivates the anti-tubercular drug, isoniazid,” Journal of Molecular Biology, vol. 318, no. 4, pp. 1071–1083, 2002. View at Publisher · View at Google Scholar · View at PubMed
  10. H. Wang, G. M. Vath, K. J. Gleason, P. E. Hanna, and C. R. Wagner, “Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies,” Biochemistry, vol. 43, no. 25, pp. 8234–8246, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. N. Zhang, L. Liu, F. Liu, C. R. Wagner, P. E. Hanna, and K. J. Walters, “NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity,” Journal of Molecular Biology, vol. 363, no. 1, pp. 188–200, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. J. Sandy, S. Holton, E. Fullam, E. Sim, and M. Noble, “Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis,” Protein Science, vol. 14, no. 3, pp. 775–782, 2005. View at Publisher · View at Google Scholar · View at PubMed
  13. A. Kawamura, J. Graham, A. Mushtaq, et al., “Eukaryotic arylamine N-acetyltransferase investigation of substrate specificity by high-throughput screening,” Biochemical Pharmacology, vol. 69, no. 2, pp. 347–359, 2005. View at Publisher · View at Google Scholar · View at PubMed
  14. J.-M. Dupret and F. Rodrigues-Lima, “Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases,” Current Medicinal Chemistry, vol. 12, no. 3, pp. 311–318, 2005.
  15. J.-M. Dupret, J. Dairou, N. Atmane, and F. Rodrigues-Lima, “Inactivation of human arylamine N-acetyltransferase 1 by hydrogen peroxide and peroxynitrite,” Methods in Enzymology, vol. 400, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. A. D. Becke, “A new mixing of Hartree-Fock and local density-functional theories,” The Journal of Chemical Physics, vol. 98, no. 2, pp. 1372–1377, 1993.
  17. A. D. Becke, “Density-functional thermochemistry. III. The role of exact exchange,” The Journal of Chemical Physics, vol. 98, no. 7, pp. 5648–5652, 1993.
  18. A. D. Becke, “Current density in exchange-correlation functionals: application to atomic states,” Journal of Chemical Physics, vol. 117, no. 15, pp. 6935–6938, 2002. View at Publisher · View at Google Scholar
  19. Gaussian03, Revision B.05, Gaussian, Inc., Pittsburgh Pa, USA, 2003.
  20. P. E. M. Siegbahn and M. R. A. Blomberg, “Transition-metal systems in biochemistry studied by high-accuracy quantum chemical methods,” Chemical Reviews, vol. 100, no. 2, pp. 421–437, 2000.
  21. P. E. M. Siegbahn, “Modeling aspects of mechanisms for reactions catalyzed by metalloenzymes,” Journal of Computational Chemistry, vol. 22, no. 14, pp. 1634–1645, 2001. View at Publisher · View at Google Scholar
  22. C. W. Bauschlicher Jr., “A comparison of the accuracy of different functionals,” Chemical Physics Letters, vol. 246, no. 1-2, pp. 40–44, 1995.
  23. L. A. Curtiss, K. Raghavachari, P. C. Redfern, and J. A. Pople, “Assessment of Gaussian-3 and density functional theories for a larger experimental test set,” Journal of Chemical Physics, vol. 112, no. 17, pp. 7374–7383, 2000.
  24. R. A. Friesner, “Ab initio quantum chemistry: methodology and applications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 19, pp. 6648–6653, 2005. View at Publisher · View at Google Scholar · View at PubMed
  25. F. Himo, “Quantum chemical modeling of enzyme active sites and reaction mechanisms,” Theoretical Chemistry Accounts, vol. 116, no. 1–3, pp. 232–240, 2006. View at Publisher · View at Google Scholar
  26. W. G. Richards, Quantum Pharmacology, Butterworths, London, UK, 2nd edition, 1983.